- Filed
- Aug 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Aug 11, 2025 | 28.15M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 27.49M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 25.46M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 19.76M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 19.47M sh |
| Capex | Q2 2025 · Jun 30, 2025 | $54K |
| Capex | Q2 2025 · Jun 30, 2024 | $12K |
| Operating Cash Flow | Q2 2025 · Jun 30, 2025 | −$11.67M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2024 | −$4.04M |
| Long Term Debt | Q2 2025 · Jun 30, 2025 | $5.08M |
| Long Term Debt | Q2 2025 · Dec 31, 2024 | $5.09M |
| Short Term Debt | Q2 2025 · Jun 30, 2025 | $187K |
| Short Term Debt | Q2 2025 · Dec 31, 2024 | $197K |
| Cash And Equivalents | Q2 2025 · Jun 30, 2025 | $4.88M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $7.13M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2024 | $10.44M |
| Stockholders Equity | Q2 2025 · Jun 30, 2025 | $40.7M |
| Stockholders Equity | Q2 2025 · Mar 31, 2025 | $43.42M |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | $44.68M |
| Stockholders Equity | Q2 2025 · Jun 30, 2024 | $53.14M |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | $51.93M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $55.23M |
| Current Liabilities | Q2 2025 · Jun 30, 2025 | $28.27M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $19.38M |
| Total Liabilities | Q2 2025 · Jun 30, 2025 | $39.75M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $30.72M |
| Current Assets | Q2 2025 · Jun 30, 2025 | $33.95M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $24.96M |
| Total Assets | Q2 2025 · Jun 30, 2025 | $80.45M |
| Total Assets | Q2 2025 · Dec 31, 2024 | $75.4M |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | −$0.13 |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | −$0.36 |
| Eps Diluted | Q2 2025 · Jun 30, 2024 | −$0.07 |
| Eps Diluted | Q2 2025 · Jun 30, 2024 | −$0.37 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | −$0.13 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | −$0.36 |
| Eps Basic | Q2 2025 · Jun 30, 2024 | −$0.07 |
| Eps Basic | Q2 2025 · Jun 30, 2024 | −$0.37 |
| Net Income | Q2 2025 · Jun 30, 2025 | −$3.59M |
| Net Income | Q2 2025 · Jun 30, 2025 | −$9.24M |
| Net Income | Q2 2025 · Jun 30, 2024 | −$1.29M |
| Net Income | Q2 2025 · Jun 30, 2024 | −$7.22M |
| Operating Income | Q2 2025 · Jun 30, 2025 | −$2.38M |
| Operating Income | Q2 2025 · Jun 30, 2025 | −$6.8M |
| Operating Income restated | Q2 2025 · Jun 30, 2024 | −$3.63M |
| Operating Income restated | Q2 2025 · Jun 30, 2024 | −$9.28M |
| Revenue | Q2 2025 · Jun 30, 2025 | $121.42M |
| Revenue | Q2 2025 · Jun 30, 2025 | $214.56M |
| Revenue | Q2 2025 · Jun 30, 2024 | $89.21M |
| Revenue | Q2 2025 · Jun 30, 2024 | $159.71M |